Mariagrazia Viganò

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

Vanesa Gregorc, Silvia Novello, Chiara Lazzari et al. · The Lancet Oncology · 2014 · 158 citations · Full text

Medicine, Molecular Medicine, Oncology +17

High-Dose Therapy and Autologous Peripheral-Blood Stem-Cell Transplantation As Salvage Treatment for HIV-Associated Lymphoma in Patients Receiving Highly Active Antiretroviral Therapy

Alessandro Re, Chiara Cattaneo, Mariagrazia Michieli et al. · Journal of Clinical Oncology · 2003 · 129 citations

Medicine, Hematology, Oncology +17

Effectiveness of Leukocyte Filters in Reducing Tumor Cell Contamination after Intraoperative Blood Salvage in Lung Cancer Patients

Paolo Perseghin, Mariagrazia Viganò, Gaetano Rocco et al. · Vox Sanguinis · 1997 · 75 citations

Medicine, Oncology, Surgery +14

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in<i>de novo</i>cardiac transplant recipients: a randomized, multicenter study

Mariagrazia Viganò, T.J. Dengler, M Mattei et al. · Transplant Infectious Disease · 2009 · 67 citations

Medicine, Infectious Diseases, Pharmacotherapy +17

Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.

Giulio Melloni, Alessandro Bandiera, Vanesa Gregorc et al. · PubMed · 2011 · 14 citations

Medicine, Neurosurgery, Surgery +15